iQ3Corp Ltd provides capital raising and corporate advisory services to listed and unlisted companies in the life science industry in Australia.
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.12|
|52 Week High||AU$0.10|
|52 Week Low||AU$0.30|
|1 Month Change||20.00%|
|3 Month Change||-20.00%|
|1 Year Change||-40.00%|
|3 Year Change||-47.83%|
|5 Year Change||-60.66%|
|Change since IPO||-76.00%|
Recent News & Updates
How Does iQ3Corp's (ASX:IQ3) CEO Pay Compare With Company Performance?
George Syrmalis has been the CEO of iQ3Corp Ltd ( ASX:IQ3 ) since 2015, and this article will examine the executive's...
|IQ3||AU Capital Markets||AU Market|
Return vs Industry: IQ3 underperformed the Australian Capital Markets industry which returned 19.3% over the past year.
Return vs Market: IQ3 underperformed the Australian Market which returned 19.3% over the past year.
Stable Share Price: Insufficient data to determine IQ3's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine IQ3's volatility change over the past year.
About the Company
iQ3Corp Ltd provides capital raising and corporate advisory services to listed and unlisted companies in the life science industry in Australia. The company operates in two segments, Consulting Services, and Shared Services. It offers advisory services on initial public offerings, listings, private equity, mergers and acquisitions, structured finance, strategic matters, restructuring and capital structure, and corporate finance.
iQ3Corp Fundamentals Summary
|IQ3 fundamental statistics|
Is IQ3 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|IQ3 income statement (TTM)|
|Cost of Revenue||AU$4.14m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.054|
|Net Profit Margin||-236.34%|
How did IQ3 perform over the long term?See historical performance and comparison
Is iQ3Corp undervalued compared to its fair value and its price relative to the market?
Share Price vs. Fair Value
Below Fair Value: IQ3 (A$0.12) is trading above our estimate of fair value (A$0.08)
Significantly Below Fair Value: IQ3 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: IQ3 is unprofitable, so we can't compare its PE Ratio to the Australian Capital Markets industry average.
PE vs Market: IQ3 is unprofitable, so we can't compare its PE Ratio to the Australian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate IQ3's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: IQ3 has negative assets, so we can't compare its PB Ratio to the AU Capital Markets industry average.
How is iQ3Corp forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Diversified Financials industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as iQ3Corp has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has iQ3Corp performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: IQ3 is currently unprofitable.
Growing Profit Margin: IQ3 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: IQ3 is unprofitable, and losses have increased over the past 5 years at a rate of 47.3% per year.
Accelerating Growth: Unable to compare IQ3's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IQ3 is unprofitable, making it difficult to compare its past year earnings growth to the Capital Markets industry (12.8%).
Return on Equity
High ROE: IQ3's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
How is iQ3Corp's financial position?
Financial Position Analysis
Short Term Liabilities: IQ3 has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: IQ3 has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: IQ3 has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: IQ3's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: IQ3 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: IQ3 has less than a year of cash runway if free cash flow continues to grow at historical rates of 2.1% each year.
What is iQ3Corp current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate IQ3's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate IQ3's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if IQ3's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if IQ3's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of IQ3's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
George Syrmalis (55 yo)
Dr. George Syrmalis, M.D., Ph D., FACNP, MAAPP, has been Chief Executive Officer at FarmaForce Limited since November 24, 2015 and has been its Executive Director since November 24, 2015. He has been Chair...
CEO Compensation Analysis
Compensation vs Market: George's total compensation ($USD533.09K) is above average for companies of similar size in the Australian market ($USD300.24K).
Compensation vs Earnings: George's compensation has increased whilst the company is unprofitable.
Experienced Board: IQ3's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
iQ3Corp Ltd's employee growth, exchange listings and data sources
- Name: iQ3Corp Ltd
- Ticker: IQ3
- Exchange: ASX
- Founded: 2012
- Industry: Asset Management and Custody Banks
- Sector: Diversified Financials
- Market Cap: AU$12.521m
- Shares outstanding: 104.34m
- Website: https://iq3corp.com
- iQ3Corp Ltd
- 85 Castlereagh Street
- Level 9
- New South Wales
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/15 07:02|
|End of Day Share Price||2021/10/13 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.